[Retracted] Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma

Table 3

Comparison of Long-term clinical efficacy.

Parameters	T-MWA group	T-CRA group	P-value
	(n = 41)%	(n = 40)%
OS
1 year	82.9% (41)	77.5% (31)	0.593
2 years	43.3% (18)	35.0% (14)	0.587
3 years	22.6%	20.0%	0.643
Median OS (month)	19.2	18.6
PFS
1 year	43.9% (18)	55.0% (22)	0.254
2 years	22.0% (90)	18.3% (7)	0.721
3 years	4.9%	5.2%	0.603
Median PFS (month)	9.3	12.3

Note. T-MWA: TACE combined with microwave ablation; T-CRA: TACE combined with radiofrequency ablation; OS: overall survival; PFS: progress free survival.